PubMed:807579 / 1125-1344
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/807579","sourcedb":"PubMed","sourceid":"807579","source_url":"http://www.ncbi.nlm.nih.gov/pubmed/807579","text":"Besides heparin-like products, having both N- and O-sulfate groups, and [14C]iduronic acid as predominant uronic acid constituent, an additional sulfated component was detected, having N-sulfate but no O-sulfate groups.","tracks":[{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T8","span":{"begin":8,"end":15},"obj":"Glycan_Motif"}],"attributes":[{"id":"A8","pred":"image","subj":"T8","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR"},{"id":"A9","pred":"image","subj":"T8","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO"},{"subj":"T8","pred":"source","obj":"GlyCosmos6-Glycan-Motif-Image"}]},{"project":"sentences","denotations":[{"id":"T10","span":{"begin":0,"end":219},"obj":"Sentence"},{"id":"T10","span":{"begin":0,"end":219},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T10","pred":"source","obj":"sentences"},{"subj":"T10","pred":"source","obj":"sentences"}]},{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T8","span":{"begin":8,"end":15},"obj":"https://glytoucan.org/Structures/Glycans/G00021MO"},{"id":"T9","span":{"begin":8,"end":15},"obj":"https://glytoucan.org/Structures/Glycans/G54161DR"}],"attributes":[{"subj":"T8","pred":"source","obj":"GlyCosmos6-Glycan-Motif-Structure"},{"subj":"T9","pred":"source","obj":"GlyCosmos6-Glycan-Motif-Structure"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"GlyCosmos6-Glycan-Motif-Image","color":"#ec9396","default":true},{"id":"sentences","color":"#93b0ec"},{"id":"GlyCosmos6-Glycan-Motif-Structure","color":"#caec93"}]}]}}